REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,029,418 | +8.6% | 145,572 | +5.0% | 0.01% | +25.0% |
| Q2 2023 | $3,709,636 | +128261.1% | 138,678 | +3.9% | 0.00% | 0.0% |
| Q1 2023 | $2,890 | +2.2% | 133,415 | +12.4% | 0.00% | 0.0% |
| Q4 2022 | $2,828 | -99.9% | 118,737 | +9.8% | 0.00% | +33.3% |
| Q3 2022 | $2,132,000 | +20.3% | 108,102 | +18.9% | 0.00% | 0.0% |
| Q2 2022 | $1,772,000 | -8.5% | 90,903 | +19.7% | 0.00% | +50.0% |
| Q1 2022 | $1,937,000 | -3.9% | 75,943 | -5.1% | 0.00% | 0.0% |
| Q4 2021 | $2,015,000 | -9.4% | 80,056 | -0.9% | 0.00% | -33.3% |
| Q3 2021 | $2,223,000 | -10.4% | 80,810 | +3.3% | 0.00% | 0.0% |
| Q2 2021 | $2,482,000 | +18.1% | 78,201 | +70.8% | 0.00% | 0.0% |
| Q1 2021 | $2,101,000 | +14.6% | 45,794 | -1.2% | 0.00% | 0.0% |
| Q4 2020 | $1,834,000 | +26.9% | 46,327 | +11.6% | 0.00% | +50.0% |
| Q3 2020 | $1,445,000 | +143.3% | 41,528 | +120.8% | 0.00% | +100.0% |
| Q2 2020 | $594,000 | +89.2% | 18,809 | +31.3% | 0.00% | 0.0% |
| Q1 2020 | $314,000 | – | 14,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |